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Data collection
Bruker APEXII CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2005) T min = 0.349, T max = 0.520 28456 measured reflections 7823 independent reflections 6784 reflections with I > 2(I) R int = 0.023 Refinement R[F 2 > 2(F 2 )] = 0.028 wR(F 2 ) = 0.073 S = 1.05 7823 reflections 227 parameters H atoms treated by a mixture of independent and constrained refinement Á max = 0.96 e Å À3 Á min = À0.50 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Cg1 and Cg2 are the centroids of the C1-C6 and C10-C15 rings, respectively. Symmetry codes: (i) Àx; Ày þ 1; Àz; (ii) x þ 1; y; z; (iii) Àx; Ày þ 1; Àz þ 1; (iv) Àx þ 1; Ày; Àz þ 1.
Data collection: APEX2 (Bruker, 2005) ; cell refinement: SAINT (Bruker, 2005) ; data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009). 3-(4-Bromophenyl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1H-pyrazole-1-carbothioamide H.-K. Fun, T. Suwunwong and S. Chantrapromma
Comment
The pyrazole moiety is one of the core structures in a number of natural products (Xie et al., 2008) . Numerous compounds which contain the pyrazole moiety are known to exhibit a wide range of biological properties such as antihypertensive (Mikhaylichenko et al., 2009) , analgesic (Hall et al., 2008) , anti-inflammatory (Bekhit et al., 2008) , antipyretic (Souza et al., 2002) , antimicrobial (Gadakh et al., 2010) , hypoglycemic (Cottineau et al., 2002) , sedative-hypnotic (Hoepping et al., 2007) and antitumor activities (Park et al., 2005) . Our on going research on biological activities of pyrazole derivatives led us to synthesize the title compound by cyclization of the chalcone derivative (Ono et al., 2007) with excess thiosemicarbazide.
Herein we report the crystal structure of the title compound.
The molecular structure of the title compound is twisted. The central pyrazole ring adopts a flattened envelope conformation with puckering parameter Q = 0.1775 (11) Å and φ = 75.9 (3)° (Cremer & Pople, 1975) , with the slightly puckered C9 atom having the maximum deviation of 0.1120 (11) Å. The pyrazole ring is coplanar with the 4-bromophenyl whereas inclined to the 4-dimethylaminophenyl rings with dihedral angles of 1.68 (6) and 85.12 (6)°, respectively. The dihedral angle between the two phenyl rings being 86.56 (6)°. The dimethylamino group is slightly twisted from the attached benzene ring with the torsion angles C16-N3-C13-C14 = 8.9 (2)° and C17-N3-C13-C12 = 8.4 (2)°. The carbothioamide is slightly twisted from the pyrazole ring as indicated by the torsions angles N4-C18-N2-N1 = 5.51 (14)° and S1-C18-N2-N1 = -172.28 (7)°. The bond distances agree with the literature values (Allen et al., 1987) and are comparable to those observed in related structures Suwunwong et al., 2009 ).
In the crystal structure ( Fig. 2) , the molecules are linked by intermolecular N-H···S hydrogen bonds (Table 1) into chains along the [2 1 0] direction. The crystal is further stabilized by C-H···π interactions (Table 1) .
Experimental
The title compound was synthesized by dissolving (E)-1-(4-bromophenyl)-3-(4-(dimethylamino)phenyl)prop-2-en-1-one (Ono et al., 2007) (0.33 g, 1.0 mmol) in a solution of KOH (0.06 g, 1.0 mmol) in ethanol (20 ml). An excess thiosemicarbazide (0.14 g, 1.5 mmol) in ethanol (20 ml) was then added, and the reaction mixture was vigorously stirred and refluxed for 7 h.
The yellow solid of the title compound obtained after cooling of the reaction mixture was filtered off under vacuum. Pale yellow block-shaped single crystals of the title compound suitable for X-ray structure determination were recrystalized from acetone/ethanol (1:1 v/v) by slow evaporation of the solvent at room temperature after several days. M.p. 481-482 K.
Refinement
The amino H atoms were located in difference Fourier map and refined isotropically. The remaining H atoms were positioned geometrically and allowed to ride on their parent atoms, with d(C-H) = 0.93 Å for aromatic, 0.97 Å for CH 2 and 0.96 Å for CH 3 atoms. The U iso values were constrained to be 1.5U eq of the carrier atom for methyl H atoms and 1.2U eq for the supplementary materials sup-2 remaining H atoms. A rotating group model was used for the methyl groups. The highest residual electron density peak is located at 0.75 Å from Br1 and the deepest hole is located at 0.56 Å from Br1. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating Rfactors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) Hydrogen-bond geometry (Å, °) Cg1 and Cg2 are the centroids of the C1-C6 and C10-C15 rings, respectively. 
